Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Exosomes from diabetic perirenal adipose-derived MSCs promote inflammation and fibrosis in diabetic nephropathy via the miR-331-3p/TSC1/mTORC1 Axis.

Zhao Y., Yin H., Tan H., Zhao Y., Shi R., Xing Y.

Animal Study on Chronic Kidney Disease, published in Int Immunopharmacol (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Int Immunopharmacol (2026)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
42419147
DOI
10.1016/j.intimp.2026.117107

Abstract (original English)

Perirenal fat, due to its anatomical proximity and secretory function, is intimately linked to renal physiology and is a rich source of mesenchymal stem cells (MSCs). However, the impact of exosomes from MSCs derived from perirenal fat under diabetic pathological conditions remains unclear. Exosomes were isolated from perirenal fat-derived MSCs of healthy and diabetic nephropathy (DN) rats. Their pro-inflammatory and pro-fibrotic effects on glomerular mesangial cells were assessed in vitro using ELISA, immunofluorescence, and Western blot. Differentially expressed miRNAs were identified by high-throughput sequencing. The targeting relationship between miR-331-3p and TSC1 was validated by a dual-luciferase reporter assay. Renal function and histopathology were evaluated in a diabetic rat model to assess therapeutic efficacy following miRNA modulation. MSCs from the perirenal fat of DN rats exhibited significant pro-inflammatory and pro-fibrotic properties compared to the healthy control group. miRNA sequencing revealed that miR-331-3p was significantly upregulated in exosomes from DN rats. Mechanistically, miR-331-3p overexpression promoted high glucose-induced inflammation and fibrosis in mesangial cells by directly targeting TSC1, leading to the activation of the mTOR signaling pathway. This effect was reversed by TSC1 overexpression. In vivo, administration of a miR-331-3p an

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsExosomesMicroRNAsDiabetic NephropathiesMesenchymal Stem CellsTuberous Sclerosis Complex 1 ProteinFibrosisRatsMaleMechanistic Target of Rapamycin Complex 1

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research